| human | Q5 |
| P496 | ORCID iD | 0000-0002-2986-1272 |
| P1053 | ResearcherID | A-7961-2010 |
| P1153 | Scopus author ID | 55531937139 |
| P108 | employer | University of Insubria | Q1309998 |
| P734 | family name | Ferrari | Q1407594 |
| Ferrari | Q1407594 | ||
| Ferrari | Q1407594 | ||
| P735 | given name | Marco | Q17520955 |
| Marco | Q17520955 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q47284305 | Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? |
| Q54250247 | Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. |
| Q46986151 | Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. |
| Q51804627 | Are CYP1A2*1F and *1C associated with clozapine tolerability?: a preliminary investigation. |
| Q42703940 | Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study. |
| Q84819013 | Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia |
| Q54373168 | Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2. |
| Q54313392 | Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol-O-methyltransferase inhibitors in Parkinson's disease patients. |
| Q44225656 | Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis |
| Q57786369 | Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines |
| Q90369761 | Clopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement |
| Q44855734 | Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes. |
| Q59649453 | Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy |
| Q44807293 | Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson's disease |
| Q44863319 | Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. |
| Q46711755 | Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients |
| Q39997081 | Expression of apoptosis-related proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease. |
| Q83336421 | Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma |
| Q55042463 | Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. |
| Q46439907 | Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis |
| Q44363779 | Interleukin-8 production induced by the endozepine triakontatetraneuropeptide in human neutrophils: role of calcium and pharmacological investigation of signal transduction pathways |
| Q24802646 | Intracellular calcium changes induced by the endozepine triakontatetraneuropeptide in human polymorphonuclear leukocytes: role of protein kinase C and effect of calcium channel blockers |
| Q42183668 | Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease |
| Q46663053 | Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up |
| Q46599107 | Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes. |
| Q43964135 | Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium |
| Q46340917 | Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis |
| Q24322222 | Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin |
| Q44641442 | Unravelling dopamine (and catecholamine) physiopharmacology in lymphocytes: open questions |
| Q48305287 | cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms. |
Search more.